Selcia’s Director of Discovery will speak at the CHI Drug Discovery Chemistry Conference at the Sheraton Hotel & Marina, San Diego, CA.
Cambridge Healthtech Institute's 12th Annual Drug Discovery Chemistry is a dynamic conference for medicinal chemists working in pharma and biotech and is focused on the discovery and optimisation challenges of small molecule drug candidates. New for 2017 is the addition of a Part 2 to the always popular Protein-Protein Interactions sessions, a track on GPCR-Targeted Drug Design, and a symposium on Small Molecules for Cancer Immunotherapy.
Selcia’s Director of Drug Discovery give a talk entitled “Discovery of Potent Cyclophilin Inhibitors Based on Structural Simplification of Sanglifehrin A” at the meeting.
Selcia's US Representative for Radiochemistry is also attending.
For more information visit the conference website